Showing results (701-710 of 2,117) with videos related to
Sort By:
Pageof 212
International Clinical Psychopharmacology|October 19, 2016
Is cerebrovascular disease a silent condition in patients with chronic schizophrenia-related disorders?Nuria Berrocal-Izquierdo, Miquel Bioque, Miguel BernardoInternational Clinical Psychopharmacology|April 4, 2017
The effect of methylphenidate on anxiety and depression symptoms in patients with Asperger syndrome and comorbid attention deficit/hyperactivity disorderPavel Golubchik, Michal Rapaport, Abraham WeizmanInternational Clinical Psychopharmacology|June 12, 2008
Clinical consequences of switching antipsychotic drugs in outpatients with schizophrenia: 36-month results from the European Schizophrenia Outpatient Health Outcomes studyDiego Novick, Josep Maria Haro, David Suarez, et al.International Clinical Psychopharmacology|February 17, 2017
Predictors of rehospitalization in a naturalistic cohort of patients with bipolar affective disorderMaria O'Hagan, Victoria Cornelius, Allan H Young, et al.International Clinical Psychopharmacology|February 25, 2017
Managing interactions between cognitive enhancers and other psychotropicsSiu W Tang, Wayne H Tang, Brian E LeonardInternational Clinical Psychopharmacology|July 1, 1989
Clonazepam and lithium--a toxic combination in the treatment of mania?D Koczerginski, S H Kennedy, R P SwinsonInternational Clinical Psychopharmacology|May 8, 2014
Prevalence of tardive dyskinesia in chronic male inpatients with schizophrenia on long-term clozapine versus typical antipsychoticsMinjie Ye, Wei Tang, Linjing Liu, et al.International Clinical Psychopharmacology|August 16, 2003
Positive effects of cerebrolysin on electroencephalogram slowing, cognition and clinical outcome in patients with postacute traumatic brain injury: an exploratory studyX Antón Alvarez, Carolina Sampedro, Paula Pérez, et al.International Clinical Psychopharmacology|August 16, 2003
Olanzapine and venous thromboembolismStaffan Hägg, Per Tätting, Olav SpigsetInternational Clinical Psychopharmacology|October 23, 2003
Incidence and determinants of antidepressant drug use in migraine patientsH Rahimtoola, H Buurma, C C Tijssen, et al.Pageof 212